Showing results (421-430 of 791) with videos related to
Sort By:
Pageof 80
Cerebrovascular Diseases (Basel, Switzerland)|January 25, 2008
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progressionA A Gouw, W M van der Flier, E C W van Straaten, et al.Neurology|July 2, 2021
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy BodiesMarcello Rossi, Simone Baiardi, Charlotte E Teunissen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2015
The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysisNienke M E Scheltens, Francisca Galindo-Garre, Yolande A L Pijnenburg, et al.Alzheimer'S Research & Therapy|November 29, 2023
How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment - a bidding game experimentI S van Maurik, E D Bakker, A A J M van Unnik, et al.Journal of Neurology|September 26, 2006
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS studyA A Gouw, W M Van der Flier, E C W van Straaten, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 24, 2020
Repeatability of parametric methods for [<sup>18</sup>F]florbetapir imaging in Alzheimer's disease and healthy controls: A test-retest studySander Cj Verfaillie, Sandeep Sv Golla, Tessa Timmers, et al.Alzheimer'S Research & Therapy|February 27, 2021
Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline resultsM van de Beek, I van Steenoven, J J van der Zande, et al.Alzheimer'S & Dementia (New York, N. Y.)|August 30, 2021
Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?Arenda Mank, Ingrid S van Maurik, Els D Bakker, et al.Neurology|March 9, 2018
Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrumLieke H H Meeter, Everard G Vijverberg, Marta Del Campo, et al.Alzheimer'S Research & Therapy|December 5, 2021
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231Sherif Bayoumy, Inge M W Verberk, Ben den Dulk, et al.Pageof 80